Linesight provided Project Cost Control services for WuXi Biologics new state-of-the-art biopharmaceutical manufacturing campus in Dundalk, Ireland.
The manufacturing facility is one of the world’s largest facilities using single-use bioreactor technology for commercial biomanufacturing, as well as next-generation processing technology.
The design of the facility reflects best-in-class industry practice and represents a step change towards the ‘Factory of the Future’ concept. The development uses innovative technology optimised for the flexible production of multiple biologic drugs for multiple customers, using single-use disposable reactors, scale-up and scale-out systems and perfusion technology.
The Linesight Project Cost Control team provided an all embracing, single point of contact for all cost related services for this project.
The Project comprises a main Manufacturing building, a Laboratory and Admin building, Warehouse, Central Utilities Building (CUB), along with associated ancillary buildings (Substation, WWTP etc.).
Data
size
status
Michael McCabe
Director
Europe
Relevant Projects
Latest News
23rd May 2023
Linesight Q1 2023 Commodity Reports
Linesight is delighted to launch the sixth edition of our Global Country Commodity Reports for Linesight Q1 2023 Commodity Reports covering the key trends and outlook for construction materials pricing and supply for 25 countries around the world.
Continue Reading15 February 2023
Linesight Q4 2022 Commodity Reports
14 February 2023
Linesight Life Sciences Benchmarking Webinar Recording